1. Home
  2. DXR vs CPIX Comparison

DXR vs CPIX Comparison

Compare DXR & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daxor Corporation

DXR

Daxor Corporation

HOLD

Current Price

$12.40

Market Cap

71.4M

Sector

Health Care

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$3.83

Market Cap

59.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DXR
CPIX
Founded
1970
1999
Country
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.4M
59.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DXR
CPIX
Price
$12.40
$3.83
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
7.4K
198.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$34.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.00
$1.85
52 Week High
$14.76
$7.25

Technical Indicators

Market Signals
Indicator
DXR
CPIX
Relative Strength Index (RSI) 45.27 47.37
Support Level $12.15 $3.68
Resistance Level $12.90 $3.98
Average True Range (ATR) 0.44 0.26
MACD 0.00 -0.02
Stochastic Oscillator 16.67 50.43

Price Performance

Historical Comparison
DXR
CPIX

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: